Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Monash IVF Group Ltd ( (AU:MVF) ) has shared an announcement.
Monash IVF Group has announced the resignation of its Chief Financial Officer and Company Secretary, Malik Jainudeen, who will remain with the company until the end of April 2026 before taking up a role with another organisation. The board has commenced a formal search for a new CFO, while acknowledging Jainudeen’s significant contribution since 2014, including his recent tenure as Acting CEO, with leadership continuity and succession planning now a short‑term focus for the group and its stakeholders.
The most recent analyst rating on (AU:MVF) stock is a Buy with a A$0.82 price target. To see the full list of analyst forecasts on Monash IVF Group Ltd stock, see the AU:MVF Stock Forecast page.
More about Monash IVF Group Ltd
Monash IVF Group Ltd is a leading provider of assisted reproductive services and specialist women’s imaging and diagnostic services, operating across Australia, Singapore, Malaysia and Indonesia. The company focuses on fertility treatment and related healthcare services for women in key Asia-Pacific markets.
Average Trading Volume: 2,262,130
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$290.3M
See more insights into MVF stock on TipRanks’ Stock Analysis page.